Projects

A randomized, assessor blind, multi center parallel arm study comparing immunogenicity potential of Teriparatide of Intas pharmaceutical limited with Forteo in post menopausal women with osteoporosis

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2021 - 2023

Project Lead

Authors

Dr Joe Joseph cherian, Dr Jovis Johny

Project Status

completed

Project Type

clinical trial